Hematopoietic Stem Cell Transplant
Conditions
Keywords
International travel, cancer patients, HSCT, Quality of Life, questionnaire, 11-176
Brief summary
The purpose of this study is to survey patients who underwent hematopoietic stem cell transplant (HSCT) to assess if they have traveled or not internationally after transplant. This information will help to improve the understanding of the needs for travel health strategies and interventions to provide healthy and safe travel to HSCT patients. The findings of this survey will also be used to develop travel health related interventions for patients living with cancer as well.
Interventions
BEHAVIORALquestionnaire
The intervention is a self-administered questionnaire that is voluntarily completed by the subject. This questionnaire has been previously validated and demonstrated to be reproducible in English speaking travelers. The final version of the survey questionnaire consists of 49 questions.Patients who never traveled after HSCT will answer only eighteen questions related to their medical and HSCT history in addition to their demographics.
Sponsors
Weill Medical College of Cornell University
Memorial Sloan Kettering Cancer Center
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Hematopoietic Stem Cell Transplant (HSCT) recipients at MSKCC from 1/1/2005 to 12/31/2010. * Age at HSCT ≥ 18 years * Permanent mailing address in the United States of America
Exclusion criteria
* Subject unable to fill the questionnaire due to language barriers.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| prevalence of international travel | 2 years | of the targeted patients Proportion of Hematopoietic Stem Cell Transplant (HSCT) patients who traveled internationally within two years after HSCT |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| travelers that becomes ill and required medical attention | 2 years | during or after return from international travel. |
| international travel was during a high-risk specific period | 2 years | Proportion of patients traveling to destinations that are at high risk areas for infections |
| patients that sought pre-travel health advice | 2 years | among those who traveled to high risk areas for infections |
Countries
United States
Outcome results
None listed